David H Deming
Director at Phio Pharmaceuticals Corp. (PHIO) since February 2025
David H Deming has filed 5 insider reports with the SEC since March 2025, as director at Phio Pharmaceuticals Corp. (PHIO). In the last 12 months David H Deming bought $19.9K of stock on the open market. In the latest filing, on November 16, 2026, David H Deming bought 12,000 shares of Phio Pharmaceuticals Corp. (PHIO) for $9,823 at an average of $0.82.
- Filings
- 5
- Companies
- 1
- Bought on market
- $19.9K
- Sold on market
- None
Companies where David H Deming is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2025 | 61,800 | $19.9K | $0.83 | $0.656-21% | Nov 16, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 13, 2026+$9,823PHIODirector Deming David H bought $9,823 worth of shares (12,000 units at $0.82), increasing direct ownership by 24% to 61,800 unitsForm 4Open-market purchase
- Nov 11, 2026+$10.1KPHIODirector Deming David H bought $10,066 worth of shares (12,000 units at $0.84), increasing direct ownership by 32% to 49,800 unitsForm 4Open-market purchase
- Feb 5, 2026PHIODirector Deming David H was granted 23,800 shares, increasing direct ownership by 170% to 37,800 unitsForm 4Grant or award
- Sep 11, 2025PHIODirector Deming David H was granted 14,000 sharesForm 4Grant or award
- Feb 19, 2025PHIODavid H Deming became an insiderForm 3New insider
Compare David H Deming with
- David H Deming vs Ronald Todd Plott1 shared
- David H Deming vs Robert J Bitterman1 shared
- David H Deming vs Lisa Cabott Carson1 shared
- David H Deming vs Patricia A Bradford1 shared
- David H Deming vs Curtis Lockshin1 shared
- David H Deming vs Jonathan E Freeman1 shared
Other insiders at the same companies
- Ronald Todd PlottPHIO
- Robert J BittermanPHIO
- Lisa Cabott CarsonPHIO
- Patricia A BradfordPHIO
- Curtis LockshinPHIO
- Jonathan E FreemanPHIO
- Robert L FerraraPHIO
Questions about David H Deming
- What is David H Deming's role at Phio Pharmaceuticals Corp.?
- David H Deming reports to the SEC as director at Phio Pharmaceuticals Corp. (PHIO), according to the latest filing on November 16, 2026.
- How many shares does David H Deming own?
- After the latest filing that states it, David H Deming directly owned 61,800 shares of Phio Pharmaceuticals Corp. (PHIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David H Deming bought or sold stock recently?
- The most recent open-market purchase was on November 13, 2026: bought 12,000 shares of Phio Pharmaceuticals Corp. (PHIO) for $9,823 at an average of $0.82.
- How do I get alerts when David H Deming files?
- Follow David H Deming on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. David H Deming filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by David H Deming (SEC CIK 0001641063). Totals count each trade once, skipping amendments whose original is on file, from Mar 4, 2025 on. View on SEC EDGAR · Get this as JSON